BION-1301 Single Dose clinical trials

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

This study is testing a new medicine, BION-1301, for people with a kidney disease called IgA Nephropathy (IgAN). The main aims are to check if the medicine is safe and how well it is tolerated in both healthy volunteers and IgAN patients.